Ignite Creation Date:
2024-05-06 @ 10:50 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03364309
Status:
COMPLETED
Last Update Posted:
2021-06-25
First Post:
2017-11-09
Brief Title:
A Study of Ixekizumab LY2439821 in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
Sponsor:
Organization:
Eli Lilly and Company